Recombinant Human CDC25 Protein，His

CDC25 phosphatases are a family of dual-specificity enzymes that play a pivotal role in regulating the cell cycle by dephosphorylating cyclin-dependent kinase (CDK) substrates, particularly during the G2/M transition. The proper functioning of CDC25 is crucial for cell cycle progression, and dysregulation of its activity is linked to various diseases, including cancer. Overexpression or mutation of CDC25 has been associated with poor prognosis in several tumor types, making it a potential target for therapeutic intervention. Research on recombinant CDC25 proteins has gained momentum as scientists aim to better understand their structural and functional properties. By expressing these proteins in suitable host systems, researchers can analyze their enzymatic activities, interactions with CDKs, and regulatory mechanisms. Additionally, the study of CDC25 in a controlled environment allows for the exploration of its role in cellular signaling pathways and its interactions with various cofactors and inhibitors. Insights gained from such investigations can contribute to the development of novel anticancer strategies that inhibit CDC25 activity, thereby providing a new avenue for targeted therapy in oncology. Ultimately, the ongoing research on CDC25 recombinant proteins not only enhances our understanding of cell cycle regulation but also holds significant promise for improving cancer treatment outcomes.